Skip to content

Opening book details…

Can I read Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases on EtoBox?

Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases by Xiaodong Dou; Huixia Huang; Yibo Li; Lan Jiang; Yanxing Wang; Hongwei Jin; Ning Jiao; Lihe Zhang; Liangren Zhang; Zhenming Liu is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases about?

Alzheimer's disease (AD) is one of the most challenging diseases around the world with no effective clinical treatment. Previous studies have suggested c-Jun N-terminal kinase 3 (JNK3) as an attractive therapeutic target for AD. Herein, we report 3-substituted indolin-2-one derivatives as the first isoform-selective JNK3 inhibitors by multistage screening. In this study, comparative structure-based virtual screening was performed, and was identified with a half-maximal inhibitory concentration of 40 nM, which exhibited over 2500-fold isoform selectivity and marked kinome-wide selectivity. Further study indicated that 1 μM exhibited neuroprotective activity in vitro so as to alleviate the spatial memory impairment in vivo through reducing plaque burden and inhibiting the phosphorylation of JNKs, Aβ precursor protein, and Tau protein. All of these indicated as proved isoform-selective JNK3 inhibitors that might serve as a useful tool for further JNK3 studies with AD as well as for the development of JNK3 inhibitors for the potential treatment of neurodegenerative diseases.

Who reads Multistage Screening Reveals 3-Substituted Indolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Xiaodong Dou; Huixia Huang; Yibo Li; Lan Jiang; Yanxing Wang; Hongwei Jin; Ning Jiao; Lihe Zhang; Liangren Zhang; Zhenming Liu
Publisher
American Chemical Society (ACS)
Published
2019
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Xiaodong Dou; Huixia Huang; Yibo Li; Lan Jiang; Yanxing Wang; Hongwei Jin; Ning Jiao; Lihe Zhang; Liangren Zhang; Zhenming Liu

Browse all works by Xiaodong Dou; Huixia Huang; Yibo Li; Lan Jiang; Yanxing Wang; Hongwei Jin; Ning Jiao; Lihe Zhang; Liangren Zhang; Zhenming Liu